Cidara Therapeutics(US:CDTX) Benzinga·2025-11-14 17:02Market Overview - U.S. stocks showed mixed performance, with the Dow Jones index falling approximately 200 points, down 0.44% to 47,249.55, while the NASDAQ rose 0.59% to 23,004.91 and the S&P 500 gained 0.27% to 6,755.73 [1] - In commodity markets, oil prices increased by 1.9% to $59.81, while gold decreased by 2.2% to $4,103.20. Silver fell 5% to $50.520 and copper dropped 1.1% to $5.0490 [5] Company Performance - Spire Inc (NYSE:SR) shares fell over 2% after reporting a quarterly loss of 47 cents per share, missing the analyst consensus estimate of a 42 cents loss. Quarterly sales were reported at $334.1 million, also below the consensus estimate of $422.094 million [2] - Cidara Therapeutics Inc (NASDAQ:CDTX) shares surged 105% to $217.18 following Merck's agreement to acquire the company for $221.50 per share in a $9.2 billion cash deal [9] - Scholar Rock Holding Corp (NASDAQ:SRRK) saw a 28% increase in shares to $38.50 after announcing a $200 million equity offering [9] - Amaze Holdings Inc (NYSE:AMZE) shares rose 61% to $0.61 after reporting third-quarter financial results [9] - TSS Inc (NASDAQ:TSSI) shares dropped 41% to $9.05 due to a year-over-year decrease in third-quarter financial results [9] - Gauzy Ltd (NASDAQ:GAUZ) shares fell 30% to $2.81 after announcing it would not release its third-quarter financial results for 2025 as previously scheduled [9] - enVVeno Medical Corp (NASDAQ:NVNO) shares decreased by 39% to $0.40 following an unfavorable FDA appeal decision regarding the VenoValve [9] International Markets - European shares declined, with the eurozone's STOXX 600 falling 1.54%, Spain's IBEX 35 Index down 1.93%, London's FTSE 100 down 1.57%, Germany's DAX 40 declining 1.34%, and France's CAC 40 dipping 1.29% [6] - Asian markets closed mostly lower, with Japan's Nikkei 225 down 1.77%, Hong Kong's Hang Seng falling 1.85%, and China's Shanghai Composite declining 0.97%. India's BSE Sensex was the only index to rise, gaining 0.10% [7]